CatalystPit
TerminalPit ConsensusInsidersPoliticiansInstitutionsNewsScreener

KPTIKaryopharm Therapeutics Inc.

NASDAQ · PHARMACEUTICAL PREPARATIONS
Last close $1.22 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryPHARMACEUTICAL PREPARATIONS
Market cap$27.67M
CountryUSA
RECENT INSIDER TRADES
  • 2026-10-02 · Abate Kristin (Chief Accounting Officer) · SELL
  • 2026-09-02 · Abate Kristin (Chief Accounting Officer) · SELL
  • 2026-07-30 · Poulton Stuart (EVP, Chief Development Officer) · SELL
  • 2026-05-26 · Oliger Christy J. (Director) · OTHER
  • 2026-05-26 · Greene Barry E (Director) · OTHER
INSTITUTIONAL OWNERSHIP
Institutional holders100
Shares held25,976,355
Value$203.23M
Percent of shares outstanding114.53%
As of quarter end2026-06-30
RECENT NEWS
  • KPTI: Karyopharm Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
  • Karyopharm Therapeutics Inc. · 8-K (1.01,2.04,3.02,8.01,9.01)
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS